Khanani, Arshad M.

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 520

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

Khanani, A. M., Patel, S. S., Ferrone, P. J., Osborne, A., Sahni, J., Grzeschik, S., Basu, K., Ehrlich, J. S., Haskova, Z., & Dugel, P. U. (2020) · JAMA Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 183

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Patel, S. S., Lally, D. R., Hsu, J., Wykoff, C. C., Eichenbaum, D., Heier, J. S., Jaffe, G. J., Westby, K., Desai, D., Zhu, L., et al. (2023) · Eye

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 147

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration

Haug, S. J., Hien, D. L., Uludag, G., Ngoc, T. T. T., Lajevardi, S., Halim, M. S., Sepah, Y. J., Do, D. V., & Khanani, A. M. (2020) · American Journal of Ophthalmology Case Reports

Ocular Diseases and Behçet’s SyndromeRetinal Diseases and Treatments

Cited by 142

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

Campochiaro, P. A., Avery, R., Brown, D. M., Heier, J. S., Ho, A. C., Huddleston, S. M., Jaffe, G. J., Khanani, A. M., Pakola, S., Pieramici, D. J., et al. (2024) · The Lancet

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 135

Review of gene therapies for age-related macular degeneration

Khanani, A. M., Thomas, M. J., Aziz, A. A., Weng, C. Y., Danzig, C. J., Yiu, G., Kiss, S., Waheed, N. K., & Kaiser, P. K. (2022) · Eye

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 119

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations

Jain, A., Chea, S., Matsumiya, W., Halim, M. S., Yaşar, Ç., Kuang, G., Sepah, Y. J., Khanani, A. M., Do, D. V., & Nguyen, Q. D. (2020) · American Journal of Ophthalmology Case Reports

Retinal Diseases and TreatmentsRetinal and Optic Conditions

Cited by 109

SIERRA-AMD: a retrospective, real-world evidence study of patients with neovascular age-related macular degeneration in the United States

Khanani, A. M., Skelly, A., Bezlyak, V., Griner, R., Torres, L. R., & Sagkriotis, A. (2020) · Ophthalmology Retina

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 96

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

Khanani, A. M., Boyer, D. S., Wykoff, C. C., Regillo, C. D., Busbee, B. G., Pieramici, D., Danzig, C. J., Joondeph, B. C., Major, J. C., Turpcu, A., et al. (2024) · eClinicalMedicine

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 76

The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter

Brown, S. M., Khanani, A. M., & McCartney, D. L. (2004) · American Journal of Ophthalmology

Glaucoma and retinal disordersOphthalmology and Visual Impairment Studies

Cited by 30

A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept

Khanani, A. M., Cohen, G. L., & Zawadzki, R. (2016) · Journal of Ocular Pharmacology and Therapeutics

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 29

Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies

Calton, M. A., Croze, R. H., Burns, C., Beliakoff, G., Vazin, T., Szymanski, P., Schmitt, C., Klein, A., Leong, M., Quezada, M., et al. (2024) · Investigative Ophthalmology & Visual Science

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 21

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration

Khanani, A. (2015) · Clinical Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 10

How could gene therapy change the way we treat age-related macular degeneration?

Khan, H., Khan, H., Aziz, A. A., Ewing, T., & Khanani, A. M. (2022) · Expert Review of Ophthalmology

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 3